(OPEN ACCESS) Provenza NR, Sheth SA, Dastin-van Rijn EM, Mathura RK, Ding Y, Vogt GS, Avendano-Ortega M, Ramakrishnan N, Peled N, Gelin LFF, Xing D, Jeni LA, Ertugrul IO, Barrios-Anderson A, Matteson E, Wiese AD, Xu J, Viswanathan A, Harrison …
(OPEN ACCESS) Meeres J, Hariz M. Stereotact Funct Neurosurg. 2022;100(3):143-155. SUMMARY Up to 30% of patients with post-traumatic stress disorder (PTSD), especially combat veterans, remain refractory to conventional treatment. For them, DBS has been suggested. The authors review the literature …
(OPEN ACCESS) Coffey RJ, Caroff SN. Stereotact Funct Neurosurg. 2022;100(3):156-167. SUMMARY The authors discuss how promising results from initial pilot studies of DBS in treatment-resistant depression (TRD) were not validated in 2 randomized, controlled, multicenter trials. Reliance on pilot data …
Escobar Vidarte OA, Griswold DP, Orozco Mera J, Arango Uribe GJ, Salcedo JC. Stereotact Funct Neurosurg. 2022 Jan 31;1-4. SUMMARY Eleven patients underwent bilateral DBS of the PMH. Their medical records were reviewed, Nine of 11 patients presented a significant …
Bourilhon J, Mullie Y, Olivier C, Cherif S, Belaid H, Grabli D, Czernecki V, Karachi C, Welter ML. Parkinsonism Relat Disord. 2022 Mar;96:13-17. SUMMARY DBS of the mesencephalic locomotor region, composed of the pedunculopontine (PPN) and cuneiform (CuN) nuclei, has …
(OPEN ACCESS) Fan H, Bai Y, Yin Z, An Q, Xu Y, Gao Y, Meng F, Zhang J. CNS Neurosci Ther. 2022 Jun 10. SUMMARY Analysis to identify the superior target of ET-DBS using PubMed, Embase, Cochrane Library, and Google …
Kondapavulur S, Silva AB, Wang DD. Stereotact Funct Neurosurg. 2022 Mar 29:1-12. SUMMARY systematic review and network meta-analysis, examining the efficacy of Vim versus PSA DBS for treating medically refractory ET. categorized outcomes as short-term (≤12 months) or long-term (>12 …
(OPEN ACCESS) de Noordhout AM, Mouchamps M, Remacle J-M, Delstanche S, Bonhomme V, Gonce M. Acta Neurol Belg. 2022 Feb;122(1):197-202. SUMMARY The authors followed over 12 years 15 parkinsonian patients having undergone STN-DBS and compared them to a matched group …
(OPEN ACCESS) Vinke RS, Selvaraj AK, Geerlings M, Georgiev D, Sadikov A, Kubben PL, Doorduin J, Praamstra P, Bloem BR, Bartels RHMA, Esselink RAJ. J Parkinsons Dis. 2022;12(4):1269-1278. SUMMARY The authors evaluate the added value of MER and intraoperative clinical …
(OPEN ACCESS) Castrioto A, Debû B, Cousin E, Pelissier P, Lhommée E, Bichon A, Schmitt E, Kistner A, Meoni S, Seigneuret E, Chabardes S, Krack P, Moro E, Fraix V. Eur J Neurol. 2022 Jun 6. SUMMARY STN DBS patients …
